Livzon Pharmaceutical repurchases A-shares, bringing total buybacks to nearly 5 million yuan

Livzon Pharmaceutical Group repurchased 131,000 A-shares on September 23, 2025, via the Shenzhen Stock Exchange. The shares were bought at prices ranging from 37.71 to 38.79 yuan per share, totaling 4,997,212 yuan. As of that date, the company's total issued A-shares remained at 604,293,313, with H-shares unchanged at 299,807,117.

The 131,000 repurchased A-shares are intended for cancellation. This activity is part of a broader program of A-share buybacks that commenced in late 2024 and continued into January, February, April, July, August, and September 2025.

The company confirmed these repurchases comply with Main Board Listing Rules and GEM Listing Rules, and all necessary regulatory approvals have been obtained.